A study protocol: a community pharmacy-based intervention for improving the management of sleep disorders in the community settings

BMC Health Services Research

Lisa M Nissen⁴  Simon S Smith³  Alesha J Smith¹  Zaswiza Mohamad Noor² 

[1] School of Pharmacy, University of Otago, North Dunedin, Dunedin 9016, New Zealand;Kulliyyah (Faculty) of Pharmacy, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, Bandar Indera Mahkota, Kuantan, Pahang 25200, Malaysia;Institute for Health and Biomedical Innovation (IHBI) and Centre of Accident Research and Road Safety (CARRSQ), Queensland University of Technology, 130 Victoria Park Road, Kelvin Grove, QLD 4059, Australia;School Clinical Sciences, Faculty of Health, Queensland University of Technology, 130 Victoria Park Road, Kelvin Grove, QLD 4059, Australia

关键词: Sleep disorders;    Actigraphy;    Community pharmacy;   

Others  :  1134105
DOI  :  10.1186/1472-6963-14-74

 received in 2012-07-24, accepted in 2014-02-13,  发布年份 2014

【 摘 要 】

Background

Sleep disorders are very common in the community and are estimated to affect up to 45% of the world’s population. Pharmacists are in a position to give advice and provide appropriate services to individuals who are unable to easily access medical care. The purpose of this study is to develop an intervention to improve the management of sleep disorders in the community. The aims are– (1) to evaluate the effectiveness of a community pharmacy-based intervention in managing sleep disorders, (2) to evaluate the role of actigraph as an objective measure in monitoring certain sleep disorders and (3) to evaluate the extended role of community pharmacists in managing sleep disorders. This intervention is developed to monitor individuals undergoing treatment and overcome the difficulties in validating self-reported feedback.

Method/design

This is a community-based intervention, prospective, controlled trial, with one intervention group and one control group, comparing individuals receiving a structured intervention with those receiving usual care for sleep-related disorders at community pharmacies.

Discussion

This study will demonstrate the utilisation and efficacy of community pharmacy-based intervention to manage sleep disorders in the community, and will assess the possibility of implementing this intervention into the community pharmacy workflow.

Trial registration

Australian New Zealand Clinical Trial Registry: ACTRN12612000825853

【 授权许可】

   
2014 Mohamad Noor et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Breathe Easily, Sleep Well: World Sleep Day Promotes Healthy, Undisturbed Sleep http://www.worldsleepday.org/press-release/ webcite], Accessed 12 June 2012
• [2]Jackson S, Peterson G: Health screening in community pharmacy: an update. Pharm 2006, 25:846-851.
• [3]Crockett J, Taylor S: Rural pharmacist perceptions of a project assessing role in the management of depression. Aust J Rural Health 2009, 17:236-243.
• [4]Bereznicki B, Peterson G, Jackson S, Haydn Walters E, DeBoos I, Hintz P: Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study. J Clin Pharm Ther 2011, 36:348-355.
• [5]Smith L, Bosnic-Anticevich SZ, Mitchell B, Saini B, Krass I, Armour C: Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Soc Sci Med 2007, 64:1501-1511.
• [6]Saini B, Krass I, Armour C: Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004, 38:1954-1960.
• [7]Emmerton L, Shaw J, Kheir N: Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther 2003, 28:395-402.
• [8]Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Saini B, Smith L, Steward K: Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007, 62:496-502.
• [9]Machado M, Bajcar J, Guzzo GC, Einarson TR: Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother 2007, 41:1569-1582.
• [10]Steil C: Managing diabetes: special patient groups: role of the C.D.E. US Pharm 1989, 14(suppl):5-6. 8, 10
• [11]Doucette WR, Witry MJ, Farris KB, McDonough RP: Community pharmacist-provided extended diabetes care. Ann Pharmacother 2009, 43:882-889.
• [12]McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT, SCRIP-HTN Investigators: A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 2008, 168:2355-2361.
• [13]Machado M, Bajcar J, Guzzo GC, Einarson TR: Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007, 41:1770-1781.
• [14]Wake Up Australia: The Value Of Healthy Sleep http://www.sleep.org.au/documents/item/69 webcite], Accessed 10 Feb 2012
• [15]Hillman DR, Murphy AS, Antic R, Pezzulo L: The economic cost of sleep disorders. SLEEP 2006, 29:299-305.
• [16]Lack L, Miller W, Turner D: A survey of sleeping difficulties in an Australian population. Community Health Stud 1988, 12:200-207.
• [17]Ely JR, Khorfan F: Unilateral periorbital swelling with nasal CPAP therapy. J Clin Sleep Med 2006, 2:330-331.
• [18]Vlachantoni IT, Dikaiakou E, Antonopoulos CN, Stefanadis C, Daskalopoulou SS, Petridou ET: Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev 2012. doi:10.1016/j.smrv.2012.01.002
• [19]National Institutes of Health: National Institutes of Health State of the Science Conference statement on manifestations and management of chronic insomnia in adults, June 13–15, 2005. SLEEP 2005, 28:1049-1058.
• [20]Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M: Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008, 4:487-504.
• [21]Richard W, Venker J, Den Herder C, Kox D, Van den Berg B, Laman M, Van Tinteren H, De Vries N: Acceptance and long-term compliance of nCPAP in obstructive sleep apnea. Eur Arch Otorhinolaryngol 2007, 264:1081-86.
• [22]Kippist C, Wong K, Bartlett D, Saini B: How do pharmacists respond to complaints of acute insomnia? A simulated patient study. Int J Clin Pharm 2011, 33:237-45.
• [23]Report of the Clinical Practice Review Committee, American Academy of Sleep Medicine: Nonprescription treatments of snoring or obstructive sleep apnea: an evaluation of products with limited scientific evidence. SLEEP 2003, 26:619-24.
• [24]Tran A, Fuller JM, Wong KK, Krass I, Grunstein R, Saini B: The development of a sleep disorder screening program in Australia community pharmacy. Pharm World Sci 2009, 31:473-80.
• [25]Hersberger KE, Renggli VP, Nirkko AC, Mathis J, Schwegler K, Bloch KE: Screening for sleep disorders in community pharmacies – evaluation of a campaign in Switzerland. J Clinical Pharmacy and Therapeutics 2006, 31:35-41.
• [26]Schwegler K, Klaghofer R, Nirkko AC, Mathis J, Hersberger KE, Bloch KE: Sleep and wakefulness disturbances in Swiss pharmacy customers. Swiss Med Weekly 2006, 136:149-54.
• [27]Fuller JM, Wong KK, Krass I, Grunstein R, Saini B: Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Educ Couns 2011, 83:325-35.
• [28]Standards of Practice Committee of the American Academy of Sleep Medicine: Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. SLEEP 2007, 30:519-29.
• [29]Standards of Practice Committee of the American Academy of Sleep Medicine: Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. SLEEP 2003, 26:337-41.
• [30]Lockley SW, Skene DJ, Arendt J: Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 1999, 8:175-83.
• [31]Vallieres A, Morin CM: Actigraphy in the assessment of insomnia. SLEEP 2003, 26:902-6.
• [32]Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP: The role of actigraphy in the study of sleep and circadian rhythms. SLEEP 2003, 26:342-92.
• [33]De Souza L, Benedito-Silva AA, Pires ML, Poyares D, Tufik S, Calil HM: Further validation of actigraphy for sleep studies. SLEEP 2003, 26:81-85.
• [34]Kushida CA, Chang A, Gadkary C, Guilleminault C, Carillo O, Dement WC: Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med 2001, 2:389-96.
• [35]Noor ZM, Smith AJ, Smith SS, Nissen LM: Feasibility and acceptability of wrist actigraph in assessing sleep quality and sleep quantity: a home-based pilot study in healthy volunteers. Health 2013, 5:63-72.
• [36]Prakash K, Nissen L, Smith S, Kyle G: Assessment and counselling provided with over-the-counter sleep request: a secret shopper study. In In proceedings of the Australasian Pharmaceutical Sciences Association annual conference (APSA). Adelaide; 11–14 December 2011
• [37]Hedner J, Pillar G, Pittman SD, Zou D, Grote L, White DP: A novel adaptive wrist actigraphy algorithm for sleep-wake assessment in sleep apnea patients. SLEEP 2004, 27:1560-66.
• [38]Mehra R, Stone KL, Ancoli-Israel S, Litwack-Harisson S, Ensrud KE, Redline S: Interpreting wrist actigraphic indices of sleep in epidemiologic studies of the elderly: the study of osteoporotic fractures. SLEEP 2008, 31:1569-76.
• [39]Lichstein KL, Stone KC, Donaldson J, Nau SD, Soeffing JP, Murray D, Lester KW, Neil Aguillard R: Actigraphy validation with insomnia. SLEEP 2006, 29:232-39.
• [40]Mccall C, Vaughn Mccall W: Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs. J Sleep Res 2012, 21:122-27.
• [41]O’Donoghue GM, Fox N, Heneghan C, Hurley DA: Objective and subjective assessment in chronic low back pain patients compared with healthy age and gender matched controls: a pilot study. BMC Musculoskelet Disord 2009, 10:122. 10.1186/1471-2474-10-122 BioMed Central Full Text
• [42]Gross CR, Kreitzer MJ, Reilly-Spong M, Wall M, Winbush NY, Patterson R, Mahowald M, Cramer-Bornemann M: Mindfulness-based stress reduction vs. Pharmacotherapy for primary chronic insomnia: a pilot randomized controlled clinical trial. Explore (NY) 2011, 7:76-87.
• [43]Sleep Right Sleep Tight: Sleep Diary http://www.nps.org.au/topics/sleep_campaign/resources/sleep_diary webcite], Accessed 6 Feb 2012
• [44]Sleep Study Report http://sleepapneafaq.wikispaces.com/Sleep+Study+report webcite], Accessed 9 July 2012
• [45]The Pharmaceutical Society of Australia: Professional Practice Standards Version 4 2010. Canberra: The Pharmaceutical Society of Australia; 2010.
• [46]WHO-5 Well Being Index http://cure4you.dk/354/WHO-5_English.pdf webcite], Accessed 12 June 2012
• [47]Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N: Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin 2007, 23:2597-605.
• [48]Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. SLEEP 1991, 14:540-45.
• [49]Johns MW: Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth sleepiness scale. Chest 1993, 103:30-6.
• [50]Bastien CH, Vallières A, Morin CM: Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001, 2:297-307.
• [51]Maislin G, Pack AI, Kribbs NB, Smith PL, Schwartz AR, Kline LR, Schwab RJ, Dinges DF: A survey screen for prediction of apnea. SLEEP 1995, 18:58-66.
• [52]Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C: Validation of the international restless legs syndrome study group rating scale for the restless legs syndrome. Sleep Med 2003, 4:121-32.
• [53]IBM SPSS Statistics 20 Documentation http://www-01.ibm.com/support/docview.wss?uid=swg27021213#en webcite], Accessed 12 June 2012
• [54]Colten HR, Altevogt BM: Sleep Disorders And Sleep Deprivation: An Unmet Public Health Problem. Washington DC: The National Academic Press; 2006.
• [55]Pandi-Perumal SR, Leger D: Sleep Disorders: Their Impact On Public Health. Oxon: Informa Healthcare; 2006.
• [56]Re-Awakening Australia: The Economic Cost Of Sleep Disorders In Australia, 2010 http://www.sleephealthfoundation.org.au/pdfs/news/Reawakening%20Australia.pdf webcite], Accessed 9 July 2012